SEI Investments’s BioSpecifics Technologies Corp. BSTC Stock Holding History

SEI Investments’s Portfolio BSTC Stock Details BSTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-2,788	Closed	-$145K	–	2910
2019 Q1	$145K	Buy	2,788 +1,128	+68%	+$74.6K	﹤0.01%	2391
2018 Q4	$74K	Buy	1,660 +1,493	+894%	+$89.2K	﹤0.01%	2264
2018 Q3	$3K	Buy	167 +86	+106%	+$4.39K	﹤0.01%	2482
2018 Q2	$4K	Sell	81 -1	-1%	-$43	﹤0.01%	3237
2018 Q1	$4K	Buy	+82	New	+$3.44K	﹤0.01%	3133
2017 Q3	–	Sell	-13	Closed	-$1K	–	3483
2017 Q2	$1K	Buy	+13	New	+$681	﹤0.01%	3008
2017 Q1	–	Sell	-13,400	Closed	-$2.2M	–	3141
2016 Q4	$2.2M	Buy	+13,400	New	+$644K	0.01%	1116
2016 Q1	–	Sell	-56	Closed	-$2K	–	2702
2015 Q4	$2K	Sell	56 -4,176	-99%	-$209K	﹤0.01%	2407
2015 Q3	$184K	Buy	4,232 +4,181	+8,198%	+$226K	﹤0.01%	1629
2015 Q2	$3K	Buy	+51	New	+$2.17K	﹤0.01%	2074
2015 Q1	–	Sell	-56	Closed	-$2K	–	2398
2014 Q4	$2K	Buy	+56	New	+$2.14K	﹤0.01%	2085

Other funds holding BSTC

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SEI Investments's BSTC Position: Q2 2019 in Review

SEI Investments sold out of BioSpecifics Technologies Corp. (BSTC) in Q2 2019, closing a stake of 2,788 shares — an estimated $145K sold.

SEI Investments first reported a position in BSTC in Q4 2014 and held it in 11 quarters. The position peaked at $2.2M in Q4 2016. 114 funds tracked by Wall St. Rank hold BSTC as of Q2 2019.

SEI Investments reported no remaining BioSpecifics Technologies Corp. position as of Q2 2019 after selling out during the quarter.
SEI Investments sold 2,788 BioSpecifics Technologies Corp. shares in Q2 2019, an estimated $145K.
SEI Investments first reported a position in BioSpecifics Technologies Corp. in Q4 2014 and held it in 11 quarters.
SEI Investments's BioSpecifics Technologies Corp. position peaked at $2.2M in Q4 2016.
114 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q2 2019.

Based on SEI Investments's 13F filing for Q2 2019, filed 14 Aug 2019.